Systematic review / meta-analysis / 2024
In a systematic review of 50 case studies, vitamin B12 deficiency-related hallucinations fully resolved in 75% of cases following cobalamin treatment.
A systematic literature search through July 1, 2023, identified 50 case studies describing hallucinations linked to vitamin B12 deficiency. Hallucinations were primarily visual and/or auditory (20% complex, compound, or panoramic) and occurred alongside conditions like dementia, delirium, and psychotic disorders. With cobalamin treatment, full amelioration of hallucinations was achieved in 75% of cases and partial amelioration in 25%, within an average of 2 months. Other neuropsychiatric manifestations disappeared in 60% of cases, and 25% of cases featured therapy-resistant hallucinations resolving under cobalamin monotherapy. Only 32% involved comorbid pernicious anaemia. The author notes findings should be interpreted with great caution given the high prevalence of B12 deficiency.
- Study type
- Systematic review of case studies
- Who was studied
- 50 published case studies (1960–2023) of hallucinations and vitamin B12 deficiency
- What was measured
- Types of hallucinations, associated neuropsychiatric conditions, response to cobalamin treatment, and presence of comorbid pernicious anaemia
THE PAPER
Hallucinations and Vitamin B12 Deficiency: A Systematic Review.
Blom JD. Psychopathology, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.